|
Editas Medicine Names Andrew Hirsch to Board of Directors
Nasdaq CAMBRIDGE, Mass., May 31, 2017 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced the appointment of Andrew Hirsch to its board of directors, effective immediately. Mr. Hirsch will also … |
June 01, 2017 at 01:34AM
from
No comments:
Post a Comment